CCL2 and neoplasm: Another work in the B16.F10 model also demonstrated that TLR7/9 stimulation with imiquimod can trigger CCL2 release by MCs to efficiently recruit plasmacytoid DCs at the tumor site, which, in turn, can directly kill tumor cells via TRAIL and granzyme B [97].